Discover
Share the concern, treatment area and change you would like to explore
Loading
Please wait while the page content is assembled.


Mounjaro is a prescription medicine containing tirzepatide. Tirzepatide activates GIP and GLP-1 receptors and may support blood-glucose control, appetite regulation, and metabolic-health management in medically suitable patients.
Mounjaro is a prescription medicine containing tirzepatide. Tirzepatide activates GIP and GLP-1 receptors and may support blood-glucose control, appetite regulation, and metabolic-health management in medically suitable patients.
01 / How it works
Tirzepatide is not insulin and does not work by physically dissolving or melting body fat. Instead, it activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In medically suitable patients with type 2 diabetes, this helps support glucose-dependent insulin release, reduces inappropriate glucagon release, and improves overall blood-glucose and HbA1c control.
Additionally, Mounjaro slows gastric emptying and interacts with appetite-regulation pathways. This can increase feelings of fullness (satiety) and reduce appetite. Where the exact product is locally authorised for adult weight management and the patient meets specific criteria (such as obesity, or overweight accompanied by qualifying weight-related health problems), these effects may support a structured medical plan. Whether you visit us from Taman Pelangi, Mount Austin, or Singapore, our doctor will explain that Mounjaro cannot guarantee weight loss and cannot replace safe nutrition and appropriate physical activity.
Mounjaro is a prescription medicine containing tirzepatide. Tirzepatide activates GIP and GLP-1 receptors and may support blood-glucose control, appetite regulation, and metabolic-health management in medically suitable patients.
Share the concern, treatment area and change you would like to explore
Shape the approach around your features, preferences and schedule
Experience a carefully planned session with clear guidance throughout
Follow simple aftercare and review how the treatment is progressing

02 / Visual guide
Mounjaro is a prescription medicine containing tirzepatide. Tirzepatide activates GIP and GLP-1 receptors and may support blood-glucose control, appetite regulation, and metabolic-health management in medically suitable patients.
Interactive treatment map
Tap a numbered point to move from your concern to the treatment approach, how it works and a personalised plan.

Start with the change you have noticed and the result you would like to explore.
Concerns & areas
Explore common areas and goals, then discuss which are most relevant to you.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Who may benefit
A consultation does not guarantee that Mounjaro will be prescribed. Prescription eligibility depends on the exact locally approved indication, adult age, BMI and waist circumference where relevant, obesity-related health conditions, type 2 diabetes status, and the prescribing doctor’s clinical assessment.
Comprehensive Review: Our doctor reviews your blood pressure, cardiovascular risk, liver health, and diabetic eye history. We assess your current medicines because combining Mounjaro with insulin or sulfonylureas can increase the risk of hypoglycaemia (low blood sugar). We also screen for severe gastroparesis, upcoming surgery plans, and review your overall nutrition and muscle health to prevent extreme calorie restriction.
What to discuss first
03 / Your treatment journey
A calm, well-explained experience at every stage.
Talk through the concern, your previous experiences and the result you would like to explore.
Review the treatment area, suitable options, expected experience and practical timing.
Arrive prepared and receive clear guidance throughout the treatment visit.
Leave with simple aftercare, helpful contact details and a plan for review.
If tirzepatide is medically indicated and prescribed, it is important to remember that individual responses differ. Some patients may notice changes in appetite or fullness before measurable metabolic or weight outcomes occur.
Ongoing Monitoring: Blood-glucose management and metabolic improvements develop over time. They depend heavily on the exact indication, medication tolerance, safe nutrition, physical activity, sleep, and your unique biology. We schedule regular clinical reviews to safely monitor gastrointestinal tolerance, kidney function where relevant, muscle health, and medication interactions.
We do not promise a guaranteed specific kilogram reduction, a smaller clothing size, or rapid permanent weight maintenance. Our patients from Tebrau, Permas Jaya, and Medini appreciate that we prioritise long-term, sustainable lifestyle support over extreme appearance-driven goals.
04 / Practical expectations
Your experience will reflect the selected treatment, treatment area and individual response. These are the useful details to explore during your visit.
05 / Compare your options
Compare the treatment approach, the area it is designed for, the experience and the way results may develop—not only the name or price.
A useful starting point when you already know the treatment and want to understand it more clearly.
Opens a wider conversation about suitable approaches, timing, recovery and natural-looking results.
Treatment gallery
Explore the consultation, treatment setting and preparation through a carefully selected visual story.
Related concerns
Begin with the concern you notice, then discover treatment approaches and questions worth bringing to your consultation.
Patient knowledge guide
Four short questions explain the treatment, suitability and why assessment matters. This quiz educates—it does not diagnose or confirm treatment eligibility.
06 / Before you decide
Responsible treatment involves understanding possible side effects and knowing when to seek help. Common adverse reactions include nausea, diarrhoea, reduced appetite, vomiting, constipation, indigestion, and abdominal discomfort. Prolonged nausea, vomiting, or diarrhoea can lead to dehydration and subsequent acute kidney injury, making proper hydration essential.
Serious risks require prompt medical assessment. Acute pancreatitis has been observed; if you experience persistent or severe abdominal pain that may spread to your back, seek urgent care. Gallbladder events like gallstones or inflammation can also occur. Current prescribing information carries a boxed warning concerning thyroid C-cell tumours observed in rats, though the human risk remains uncertain. Additionally, because Mounjaro delays gastric emptying, there is a rare risk of pulmonary aspiration during general anaesthesia or deep sedation. You must inform your healthcare team before any surgical or dental procedures.
Read about informed consent07 / Recovery
You will receive treatment-specific guidance on what to expect, how to care for the area and when to contact the clinic with a question.
Contact the clinic08 / FAQ
Helpful answers for planning your consultation and understanding the treatment experience.
Tirzepatide is not insulin and does not work by physically dissolving or melting body fat. Instead, it activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In medically suitable patients with type 2 diabetes, this helps support glucose-dependent insulin release, reduces inappropriate glucagon release, and improves overall blood-glucose and HbA1c control.
If tirzepatide is medically indicated and prescribed, it is important to remember that individual responses differ. Some patients may notice changes in appetite or fullness before measurable metabolic or weight outcomes occur.
Mounjaro is a prescription medicine containing tirzepatide. Tirzepatide activates GIP and GLP-1 receptors and may support blood-glucose control, appetite regulation, and metabolic-health management in medically suitable patients.
No. It is a prescription metabolic medicine and should not be used as a beauty treatment, body-shaping injection, or shortcut for becoming thin. Treatment supports sustainable health goals, not appearance pressure.
No. Mounjaro and Zepbound both contain tirzepatide but may have different indications and labels depending on the country. Ozempic and Wegovy contain semaglutide. Different medicines have distinct uses and safety profiles.
Current US prescribing information lists personal or family history of medullary thyroid carcinoma (MTC), MEN 2, and previous serious hypersensitivity to tirzepatide or its ingredients as strict contraindications. Local Malaysian product information must also be verified.
Plan your next step
Share your goals with the Eco Botanic team and begin with a personalised consultation.